Related Experiment Videos
Maternal plasma beta-hCG in early human pregnancy
British Journal of Obstetrics and Gynaecology
|August 1, 1980
Summary
Plasma beta-human chorionic gonadotrophin (beta-hCG) levels show a distinct pattern during early pregnancy, rising to a peak around week 11 before declining. These levels can indicate pregnancy outcomes, with significant deviations suggesting abnormalities.
Area of Science:
- Reproductive Endocrinology
- Maternal-Fetal Medicine
- Biochemistry
Background:
- Beta-human chorionic gonadotrophin (beta-hCG) is a key hormone in pregnancy.
- Understanding beta-hCG dynamics is crucial for monitoring pregnancy progression and detecting potential complications.
- Previous studies have established general trends of hCG, but detailed beta-hCG plasma profiles require further investigation.
Purpose of the Study:
- To characterize the typical plasma beta-human chorionic gonadotrophin (beta-hCG) profile throughout early gestation (4-16 weeks).
- To investigate the correlation between plasma beta-hCG levels and pregnancy outcomes, including normal pregnancies, twin pregnancies, abortions, and pregnancies with progestogen therapy.
- To compare the trends of plasma beta-hCG with plasma hCG levels.
Main Methods:
- Plasma beta-hCG levels were measured twice weekly in 20 subjects from 4 to 16 weeks of gestation.
- Subjects included 14 normal pregnancies and 6 with abnormal outcomes (twin pregnancy, abortion, progestogen therapy).
- Statistical analysis was performed to compare mean levels and assess deviations from the norm.
Main Results:
- Plasma beta-hCG levels exhibited a rise, plateau (weeks 7-9), peak (week 11), and subsequent decline to week 16 in normal pregnancies.
- No significant difference in mean beta-hCG levels was observed based on the baby's sex.
- Abnormal pregnancies showed deviations: twin pregnancy levels were elevated (1-SD above mean at 11-13 weeks), and aborted pregnancies had lower levels (1-SD below mean at week 5).
- Beta-hCG levels in subjects on progestogen therapy fluctuated within normal limits.
- Plasma beta-hCG trends mirrored plasma hCG trends, but peak timing differed.
Conclusions:
- Plasma beta-hCG levels follow a predictable pattern in early pregnancy, with significant variations potentially indicating adverse outcomes.
- Monitoring beta-hCG is valuable for assessing pregnancy viability and detecting complications like abortion or twin gestations.
- Considerable inter- and intra-patient variability in beta-hCG levels necessitates careful interpretation in clinical practice.